While the CSF3R T618I mutation remains a hallmark of CNL (reported in up to 83% of cases) and is also present in aCML [17], our findings reinstate that this mutation is not restricted to these entities. The gene discussed is CSF3R; the disease is atypical chronic myeloid leukemia, BCR-ABL1 negative.